Foresters Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CI
Foresters Investment Management's XBI Position: Q3 2019 in Review
Foresters Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2019, closing a stake of 56,900 shares — an estimated $4.99M sold.
Foresters Investment Management first reported a position in XBI in Q3 2018 and held it in 4 quarters. The position peaked at $5.93M in Q1 2019. 406 funds tracked by Wall St. Rank hold XBI as of Q3 2019.
- Foresters Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2019 after selling out during the quarter.
- Foresters Investment Management sold 56,900 State Street SPDR S&P Biotech ETF shares in Q3 2019, an estimated $4.99M.
- Foresters Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 4 quarters.
- Foresters Investment Management's State Street SPDR S&P Biotech ETF position peaked at $5.93M in Q1 2019.
- 406 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2019.
Based on Foresters Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.